| 10-Q | 2020-03-31 | Filed 2020-05-22 |
| 10-Q | 2019-12-31 | Filed 2020-02-11 |
| 10-K | 2019-09-30 | Filed 2020-01-14 |
| 10-Q | 2019-06-30 | Filed 2019-08-12 |
| 10-Q | 2019-03-31 | Filed 2019-05-14 |
| 10-Q | 2018-12-31 | Filed 2019-02-11 |
| 10-K | 2018-09-30 | Filed 2018-12-31 |
| 10-Q | 2018-06-30 | Filed 2018-08-14 |
| 10-Q | 2018-03-31 | Filed 2018-05-14 |
| 10-Q | 2017-12-31 | Filed 2018-02-13 |
| 10-K | 2017-09-30 | Filed 2017-12-29 |
| 10-Q | 2017-06-30 | Filed 2017-08-04 |
| 10-Q | 2017-03-31 | Filed 2017-05-11 |
| 10-Q | 2016-12-31 | Filed 2017-02-13 |
| 10-K | 2016-09-30 | Filed 2016-11-17 |
| 10-Q | 2016-06-30 | Filed 2016-08-15 |
| 10-Q | 2016-03-31 | Filed 2016-05-25 |
| 8-K | 2020-05-12 | |
| 8-K | 2019-08-21 | |
| 8-K | 2019-07-15 | |
| 8-K | 2019-04-29 | |
| 8-K | 2018-08-06 | |
| 8-K | 2018-06-28 | |
| 8-K | 2018-05-04 |
| Comps ($'000 TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Kaleido Biosciences (KLDO) | 222,412 | -2.4 | -73% | 91,212 | 25,172 | 0 | 0 | -66,819 | -65,079 | 153,821 | |
| Citizens Financial Services (CZFS) | 219,586 | 0% | 5.7 | 1% | 1,475,005 | 1,323,327 | 5,197 | 0 | 18,962 | 34,712 | 199,500 |
| Emergent Capital (EMG) | 177,018 | 0% | -5.2 | -69% | 85,384 | 121,307 | 35,301 | 0 | -58,692 | -33,490 | 175,594 |
| Isabella Bank (ISBA) | 218,480 | 0% | 6.3 | 1% | 1,813,684 | 1,601,308 | 4,294 | 0 | 12,126 | 29,281 | 184,149 |
| Crimson Wine Group (CWGL) | 217,967 | 41% | 169.4 | -2% | 247,334 | 40,543 | 66,627 | 27,638 | -3,816 | 1,332 | 225,647 |
| Xerium Technologies (XRM) | 217,666 | 10% | 24.6 | -3% | 547,188 | 698,205 | 486,466 | 48,974 | -16,156 | 30,283 | 743,584 |
| Exicure (XCUR) | 212,785 | 0% | -7.2 | -29% | 73,806 | 8,854 | 992 | 0 | -21,077 | -20,488 | 147,392 |
| Powercomm Holdings (PCC) | 210,454 | 29% | 84.1 | 29% | 5,177 | 4,207 | 10,712 | 3,081 | 1,486 | 2,500 | 210,300 |
| Bovie Medical (BVX) | 206,243 | 65% | -11.4 | -15% | 86,943 | 10,210 | 25,892 | 16,732 | -13,330 | -12,697 | 144,111 |
| Bicycle Therapeutics (BCYC) | 200,512 | 0% | -5.3 | -17% | 116,060 | 20,735 | 2,136 | 0 | -19,699 | -19,652 | 104,558 |
| Fuse Enterprises (FSNT) | 200,164 | 86% | -191.4 | -95% | 1,099 | 2 | 1,016 | 870 | -1,046 | -1,046 | 200,124 |
| Solbright (SBRT) | 195,093 | -11% | -4.2 | -411% | 12,978 | 107,736 | 3,481 | -399 | -53,291 | -45,982 | 194,304 |
| HOOKIPA Pharma (HOOK) | 197,170 | 0% | -2.3 | -22% | 152,037 | 26,280 | 8,324 | 0 | -32,793 | -32,034 | 73,160 |
| Corvus Gold (CORVF) | 170,478 | -15.3 | -106% | 10,214 | 765 | 0 | 0 | -10,858 | -10,858 | 166,332 | |
| Union Bridge Holdings (UGHL) | 188,095 | 26% | -422.5 | -815% | 55 | 977 | 65 | 17 | -445 | -445 | 188,075 |
| IDEAYA Biosciences (IDYA) | 186,410 | -3.7 | -18% | 122,331 | 11,925 | 0 | 0 | -21,625 | -21,025 | 77,010 | |
| GrowGeneration (GRWG) | 182,705 | 29% | 57.2 | 3% | 68,417 | 15,626 | 54,349 | 16,008 | 2,341 | 2,923 | 167,194 |
| Technovative Group (TEHG) | 182,172 | 57% | -105.6 | -33% | 5,191 | 3,101 | 765 | 437 | -1,719 | -1,719 | 181,597 |
| Exagen (XGN) | 182,113 | 54% | -60.9 | -3% | 92,744 | 34,094 | 10,439 | 5,656 | -3,141 | -2,132 | 129,862 |
| Soliton (SOLY) | 179,964 | -14.9 | -130% | 9,927 | 2,745 | 0 | 0 | -12,896 | -11,529 | 171,255 |
| Balance Sheet ($'000) | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 |
| Cash | 10 | 28 | 8 | 6,848 | 3,293 | 894 | 419 | 4,103 | 3,772 | 876 | 103 | 94 | 64 | 40 |
| Accounts Receivable | 20 | 50 | ||||||||||||
| Inventory | ||||||||||||||
| PP&E | 3 | 3 | 2 | 0 | 14 | 14 | 13 | 12 | 12 | 11 | 11 | 10 | 10 | 9 |
| Assets | 13 | 31 | 19 | 6,854 | 6,442 | 5,839 | 5,357 | 5,115 | 4,801 | 2,149 | 1,189 | 1,122 | 1,074 | 1,099 |
| Accounts Payable | ||||||||||||||
| Long-Term Debt | ||||||||||||||
| Liabilities | 29 | 34 | 35 | 6,873 | 6,962 | 6,875 | 6,879 | 6,877 | 6,915 | 6,927 | 10 | 5 | 6 | 2 |
| Stockholders' Equity | -16 | -3 | -16 | -19 | -520 | -1,036 | -1,522 | -1,762 | -2,114 | -4,778 | 1,180 | 1,117 | 1,068 | 1,097 |
| Income Statement ($'000) | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 |
| Revenue | 8 | 4 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 516 | 250 | 250 | ||
| Cost of Revenue | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 89 | 57 | ||
| Gross Profit | 6 | 2 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 516 | 161 | 193 | ||
| R&D | ||||||||||||||
| SG&A | 37 | 485 | 514 | 483 | 228 | 308 | 167 | 172 | 134 | 181 | 145 | |||
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | |
| Net Income | -9 | -22 | -13 | -38 | -518 | -516 | -486 | -239 | -76 | -2,664 | -964 | -62 | -50 | 29 |
| Cash Flow ($'000) | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 |
| Cash Operating | -17 | -20 | -42 | -1,606 | -398 | -475 | -242 | -331 | -2,896 | -772 | -10 | -30 | -24 | |
| Cash Investing | 0 | 0 | 0 | -1,940 | -2,000 | 0 | 3,925 | 0 | 0 | 0 | ||||
| Cash Financing | 35 | 0 | 6,881 | -10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |